Login / Signup

The first report of leukocytoclastic vasculitis induced by once-weekly subcutaneous semaglutide.

Marcelo Maia PinheiroLuciana Gasques de SouzaGuilherme Pavini NunesIsis Franco MartinYasmin Utuari de OliveiraFelipe Moura Maia PinheiroLygia Nazário CostaMassimiliano CaprioDavid Della-MorteMarco Infante
Published in: Current medical research and opinion (2024)
Future prospective studies, adverse event reporting and post-marketing surveillance will certainly contribute to establishing if LCV represents a less rare than expected side effect of both oral and subcutaneous semaglutide formulations.
Keyphrases
  • adverse drug
  • public health
  • current status
  • case control